Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study

dc.authoridARICI, MUSTAFA/0000-0002-4055-7896
dc.authoridDheir, Hamad/0000-0002-3569-6269
dc.authoridsezer, siren/0000-0002-7326-8388
dc.authoridSahin, Gulizar Manga/0000-0002-0409-2710
dc.authoridDolarslan, Murside Esra/0000-0002-8669-4212
dc.authoridhur, ender/0000-0002-8066-4629
dc.authoridSahin, Idris/0000-0002-8683-3737
dc.authorwosidPembegul, Irem/HJA-2191-2022
dc.authorwosidARICI, MUSTAFA/I-9265-2013
dc.authorwosidSENGUL, Erkan/J-8295-2012
dc.authorwosidDheir, Hamad/CAH-8663-2022
dc.authorwosidPembegul, Irem/AAB-6645-2022
dc.authorwosidsezer, siren/JYQ-2550-2024
dc.authorwosidSahin, Gulizar Manga/HKV-4703-2023
dc.contributor.authorOzturk, Savas
dc.contributor.authorTurgutalp, Kenan
dc.contributor.authorArici, Mustafa
dc.contributor.authorGok, Mahmut
dc.contributor.authorIslam, Mahmud
dc.contributor.authorAltiparmak, Mehmet Riza
dc.contributor.authorAydin, Zeki
dc.date.accessioned2024-08-04T20:50:22Z
dc.date.available2024-08-04T20:50:22Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjective Older adults with co-morbidities have been reported to be at higher risk for adverse outcomes of coronavirus disease 2019 (COVID-19). The characteristics of COVID-19 in older patients and its clinical outcomes in different kidney disease groups are not well known. Methods Data were retrieved from a national multicentric database supported by Turkish Society of Nephrology, which consists of retrospectively collected data between 17 April 2020 and 31 December 2020. Hospitalised patients aged 18 years or older with confirmed COVID-19 diagnosis suffering from stage 3-5 chronic kidney disease (CKD) or on maintenance haemodialysis (HD) treatment were included in the database. Non-uraemic hospitalised patients with COVID-19 were also included as the control group. Results We included 879 patients [388 (44.1%) female, median age: 63 (IQR: 50-73) years]. The percentage of older patients in the CKD group was 68.8% (n = 188/273), in the HD group was 49.0% (n = 150/306) and in the control group was 30.4% (n = 70/300). Co-morbidities were higher in the CKD and HD groups. The rate of presentation with severe-critical disease was higher in the older CKD and HD groups (43.6%, 55.3% and 16.1%, respectively). Among older patients, the intensive care unit (ICU) admission rate was significantly higher in the CKD and HD groups than in the control group (38.8%, 37.3% and 15.7%, respectively). In-hospital mortality or death and/or ICU admission rates in the older group were significantly higher in the CKD (29.3% and 39.4%) and HD groups (26.7% and 30.1%) compared with the control group (8.6% and 17.1%). In the multivariate analysis, in-hospital mortality rates in CKD and HD groups were higher than control group [hazard ratio (HR): 4.33 (95% confidence interval [CI]: 1.53-12.26) and HR: 3.09 (95% CI: 1.04-9.17), respectively]. Conclusion Among older COVID-19 patients, in-hospital mortality is significantly higher in those with stage 3-5 CKD and on maintenance HD than older patients without CKD regardless of demographic characteristics, co-morbidities, clinical and laboratory data on admission.en_US
dc.identifier.doi10.1111/ijcp.14428
dc.identifier.issn1368-5031
dc.identifier.issn1742-1241
dc.identifier.issue9en_US
dc.identifier.pmid34085352en_US
dc.identifier.scopus2-s2.0-85108331460en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1111/ijcp.14428
dc.identifier.urihttps://hdl.handle.net/11616/99997
dc.identifier.volume75en_US
dc.identifier.wosWOS:000662739800001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWiley-Hindawien_US
dc.relation.ispartofInternational Journal of Clinical Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectRenal-Diseaseen_US
dc.subjectMortalityen_US
dc.subjectRisken_US
dc.subjectHemodialysisen_US
dc.subjectPopulationen_US
dc.subjectInfectionen_US
dc.subjectDeathen_US
dc.titleCharacteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled studyen_US
dc.typeArticleen_US

Dosyalar